QinetiQ Group PLC — Investor Relations & Filings
QinetiQ Group PLC is a science and engineering company that provides technology-based products and services primarily to the global defence and security sectors. The company's core activities include research and development, advisory services, and comprehensive test and evaluation (T&E) for air, land, and maritime systems. Key offerings encompass uncrewed air, land, and surface target systems for live-fire training and weapons system assessment; cybersecurity services and training; and advanced training and mission rehearsal solutions. QinetiQ focuses on mission-led innovation, applying its expertise to modernize military platforms and enhance critical technologies to address complex operational challenges for its customers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Transaction in Own Shares | 2026-05-05 | English | |
| Total Voting Rights | 2026-04-30 | English | |
| Transaction in Own Shares | 2026-04-28 | English | |
| Transaction in Own Shares | 2026-04-21 | English | |
| Transaction in Own Shares | 2026-04-14 | English | |
| Director/PDMR Shareholding | 2026-04-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41305975 | Transaction in Own Shares | 2026-05-05 | English | ||
| 39110066 | Total Voting Rights | 2026-04-30 | English | ||
| 37867061 | Transaction in Own Shares | 2026-04-28 | English | ||
| 34696665 | Transaction in Own Shares | 2026-04-21 | English | ||
| 34655068 | Transaction in Own Shares | 2026-04-14 | English | ||
| 34088310 | Director/PDMR Shareholding | 2026-04-10 | English | ||
| 33558607 | Director/PDMR Shareholding | 2026-04-01 | English | ||
| 33117229 | Total Voting Rights | 2026-03-31 | English | ||
| 33084543 | Transaction in Own Shares | 2026-03-30 | English | ||
| 33039702 | Holding(s) in Company | 2026-03-25 | English | ||
| 33037959 | Share Buyback Programme | 2026-03-25 | English | ||
| 33037721 | Transaction in Own Shares | 2026-03-25 | English | ||
| 33018331 | Transaction in Own Shares | 2026-03-24 | English | ||
| 33011138 | Transaction in Own Shares | 2026-03-23 | English | ||
| 32996656 | Transaction in Own Shares | 2026-03-20 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for QinetiQ Group PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CALIWAY BIOPHARMACEUTICALS CO., LTD.
Develops small-molecule therapeutics for medical aesthetics…
|
6919 | TW | Professional, scientific and te… |
|
CALIX LIMITED
Develops industrial carbon capture and sustainable mineral …
|
CXL | AU | Professional, scientific and te… |
|
CAMBIUM BIO LIMITED
Clinical-stage developer of cellular therapies for ophthalm…
|
CMB | AU | Professional, scientific and te… |
|
CAMBRIDGE COGNITION HOLDINGS PLC
Develops digital solutions and a platform for CNS clinical …
|
COG | GB | Professional, scientific and te… |
|
CanBas Co.,Ltd.
A clinical-stage biopharmaceutical company developing novel…
|
4575 | JP | Professional, scientific and te… |
|
Captor Therapeutics S.A.
Develops Targeted Protein Degradation therapies for cancer …
|
CTX | PL | Professional, scientific and te… |
|
Cardiff Oncology, Inc.
A clinical-stage biotech developing cancer therapies that i…
|
CRDF | US | Professional, scientific and te… |
|
Cardio Diagnostics Holdings, Inc.
Develops AI-powered epigenetic and genetic tests for early …
|
CDIO | US | Professional, scientific and te… |
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory therapi…
|
CRDL | CA | Professional, scientific and te… |
|
CASSAVA SCIENCES INC
Clinical-stage biotech developing treatments for Central Ne…
|
SAVA | US | Professional, scientific and te… |
QinetiQ Group PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4849/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4849 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4849 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4849 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4849}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for QinetiQ Group PLC (id: 4849)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.